Invitation to presentation of MEDS 2025 year-end report on February 10, 2026
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
MEDS will publish its 2025 year-end report on February 10, 2026, at 07:30 CET. A webcast presentation will be held for analysts, media, and investors at 09:30 CET the same day.
The report will be presented by Björn Thorngren, CEO and co-founder, and Nick Mendola, CFO.
The presentation will be conducted in English and broadcast live online. Please email ir@meds.se to receive a link to the live presentation (at latest 09:00 CET on 10th of February).
A recorded version of the presentation will be available later at: Rapporter och presentationer | MEDS Investor Relations
Schedule for the 10th of February:
- 07:30 CET – Publication of the Q4 report
- 9:30 CET – Webcast and conference call with CEO Björn Thorngren and CFO Nick Mendola
For further information, please contact:
Frida Benno Hjerpe
MEDS Press & Investor Relations
E-mail: press@meds.se
Web: https://corporate.meds.se/
About MEDS
MEDS.se is a full-scale online pharmacy licensed by the Swedish Medical Products Agency. We provide both prescription and over-the-counter medicines for you, your family, and your pets.
In addition, MEDS offers a wide range of products in health, beauty, and wellness.
Certified advisor is FNCA.